2015
DOI: 10.1016/j.jaad.2014.10.011
|View full text |Cite
|
Sign up to set email alerts
|

Topical rapamycin combined with pulsed dye laser in the treatment of capillary vascular malformations in Sturge-Weber syndrome: Phase II, randomized, double-blind, intraindividual placebo-controlled clinical trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
81
1
1

Year Published

2015
2015
2021
2021

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 93 publications
(84 citation statements)
references
References 31 publications
1
81
1
1
Order By: Relevance
“…In contrast, considerable revascularization of the PDL-only sites was observed. Furthermore, in a clinical study involving 23 subjects with Sturge-Weber syndrome and PWS, Marqués et al [120] reported that the combination of PDL and topical rapamycin led to a higher degree of blanching than PDL alone.…”
Section: Development Of New Treatment Approachesmentioning
confidence: 99%
“…In contrast, considerable revascularization of the PDL-only sites was observed. Furthermore, in a clinical study involving 23 subjects with Sturge-Weber syndrome and PWS, Marqués et al [120] reported that the combination of PDL and topical rapamycin led to a higher degree of blanching than PDL alone.…”
Section: Development Of New Treatment Approachesmentioning
confidence: 99%
“…However, the extent to which these lesions may improve varies widely and complete resolution is infrequent. 12 Woo et al reported only 2% of patients with complete disappearance of lesion after a mean of 17 treatment sessions. 13 While PDL is very effective in producing initial lightening of PWS lesions, there is a subsequent revascularization after laser therapy that results in frequent treatment failure.…”
Section: Discussionmentioning
confidence: 99%
“…15,16 Resolution of PWS, as defined by persistent blanching of the lesion, is reported in less than 10%-20% of cases. 12,[17][18][19][20] Early intervention is indicated to prevent the development of hypertrophy and nodularity, which has been shown to increase treatment resistance. 12,21 Thickened PWS lesions at older age have been associated with increased therapeutic failure.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Although most currently used drugs do not directly affect the GLU receptors, new-generation AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptor antagonists, such as perampanel, can inhibit GLU-mediated excitation, and may be considered for SWS epilepsy treatment in the future as clinical experience with such drugs becomes available in pediatric populations (Biro et al, 2015; Rosenfeld et al, 2015). Another therapeutic option would involve inhibition of mammalian target of rapamycin (mTOR) complex 1 signaling that may not only reverse increases of glutamatergic neurotransmission (Talos et al, 2012) but could also be beneficial to treat the vascular malformation (Marques et al, 2015; Shirazi et al, 2007). …”
Section: Discussionmentioning
confidence: 99%